184 related articles for article (PubMed ID: 20601462)
41. Effects of olmesartan on arterial stiffness in rats with chronic renal failure.
Chuang YC; Wu MS; Su YK; Fang KM
Cardiovasc Diabetol; 2012 Jun; 11():66. PubMed ID: 22694778
[TBL] [Abstract][Full Text] [Related]
42. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
43. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
44. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats.
Sheng H; Zhu J; Wu X; Yang D; Zhang J
Hypertens Res; 2007 Dec; 30(12):1247-54. PubMed ID: 18344631
[TBL] [Abstract][Full Text] [Related]
46. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
[TBL] [Abstract][Full Text] [Related]
47. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
[TBL] [Abstract][Full Text] [Related]
48. Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.
Ghosh SS; Krieg RJ; Sica DA; Wang R; Fakhry I; Gehr T
Pediatr Nephrol; 2009 Feb; 24(2):367-77. PubMed ID: 18797934
[TBL] [Abstract][Full Text] [Related]
49. Cardiomyocyte loss in experimental renal failure: prevention by ramipril.
Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G
Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of converting enzyme and thromboxane synthetase in a model of progressive renal disease; effects of enalapril and RS-86328 in the rat.
Rosenkranz RP; Hayashi CM
Proc West Pharmacol Soc; 1988; 31():81-5. PubMed ID: 2850566
[No Abstract] [Full Text] [Related]
51. Netrin-1 attenuates the progression of renal dysfunction by blocking endothelial-to-mesenchymal transition in the 5/6 nephrectomy rat model.
Bai J; Hao J; Zhang X; Cui H; Han J; Cao N
BMC Nephrol; 2016 May; 17(1):47. PubMed ID: 27176224
[TBL] [Abstract][Full Text] [Related]
52. Cardioprotective effect of renalase in 5/6 nephrectomized rats.
Baraka A; El Ghotny S
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):412-6. PubMed ID: 22626958
[TBL] [Abstract][Full Text] [Related]
53. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
54. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
[TBL] [Abstract][Full Text] [Related]
55. Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.
Freundlich M; Li YC; Quiroz Y; Bravo Y; Seeherunvong W; Faul C; Weisinger JR; Rodriguez-Iturbe B
Am J Hypertens; 2014 May; 27(5):720-6. PubMed ID: 24072555
[TBL] [Abstract][Full Text] [Related]
56. Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?
Liu WH; Tang NN; Zhang QD
Chin Med J (Engl); 2009 Jan; 122(2):199-204. PubMed ID: 19187647
[TBL] [Abstract][Full Text] [Related]
57. ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.
Simolin MA; Pedersen TX; Bro S; Mäyränpää MI; Helske S; Nielsen LB; Kovanen PT
BMC Cardiovasc Disord; 2009 Mar; 9():10. PubMed ID: 19257900
[TBL] [Abstract][Full Text] [Related]
58. Effect of dietary salt restriction on tubular hypertrophy in rats with early-stage chronic renal failure.
Okada K; Matsumoto K
Scand J Urol Nephrol; 2004; 38(4):326-31. PubMed ID: 15669593
[TBL] [Abstract][Full Text] [Related]
59. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.
Spencer AG; Labonte ED; Rosenbaum DP; Plato CF; Carreras CW; Leadbetter MR; Kozuka K; Kohler J; Koo-McCoy S; He L; Bell N; Tabora J; Joly KM; Navre M; Jacobs JW; Charmot D
Sci Transl Med; 2014 Mar; 6(227):227ra36. PubMed ID: 24622516
[TBL] [Abstract][Full Text] [Related]
60. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats].
Heller J; Cervenka L; Hellerová S
Cas Lek Cesk; 1994 Jul; 133(14):429-33. PubMed ID: 8069900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
